Point-of-care advertising is a sequence of moments. Care Sequence connects all.

Point of care advertising, also written point-of-care advertising, places pharmaceutical brand messages inside the clinical environment and the clinical workflow — waiting-room and exam-room screens, the EHR a physician works in, the patient portal, and the pharmacy management system a pharmacist uses. Unlike general HCP advertising, it is delivered at the moment a diagnosis, prescription or dispensing decision is actually being made.

Buyers shortlisting point of care advertising companies should ask five questions. How many moments of the patient journey does the vendor actually reach? What activates the message? Where does the clinical data come from? How does the data move? And who carries the compliance risk?

EHR advertising delivers messages to a physician inside the electronic health record during the clinical workflow — at patient intake, diagnostic ordering, diagnosis review, medication review and prescribing. It is one part of point-of-care advertising: it covers the prescribing side of the encounter, but not the patient before the visit or the pharmacist at the fill.

Prescriptions are most often abandoned at the pharmacy counter because of cost, an unexpected co-pay, or a prior authorization the patient did not anticipate. Roughly one in three new prescriptions is never picked up. None of these causes are visible when the prescription is written, which is why the dispensing moment matters commercially.

Closed-loop measurement connects media investment through reach and engagement to a prescribing outcome. In pharma that means tying spend to NRx, TRx and NBRx with physician-level data, rather than stopping at impressions and clicks. A read without a matched control is not evidence, because prescribing volumes move with seasonality and formulary changes.

MLR is the medical, legal and regulatory review every piece of pharmaceutical promotional material must clear before it runs. For point-of-care advertising it covers the creative, the claims, and the trigger rules that determine when a message fires. Delivering assets and rule logic in an MLR-ready format is what shortens the cycle.

Point of care marketing is the practice of reaching patients, physicians and pharmacists inside the care setting rather than through mass media. It became a channel exceeding one billion dollars in annual US spend because relevance concentrates where clinical context exists — a message delivered where a diagnosis is being recorded carries information the same message on a news site cannot.

HCP advertising is the paid-media half of HCP marketing. It is media directed at healthcare professionals rather than patients, covering physicians, nurse practitioners, physician assistants and pharmacists. It spans endemic medical media, programmatic display against verified NPIs, email to verified providers, and in-workflow placements inside the EHR at the point of prescribing.

NPI targeting reaches an individual healthcare provider by their verified National Provider Identifier, one to one, rather than through a segment built to resemble them. On its own it answers who. Layering it with the provider's live workflow step and the coded clinical event answers when — which is usually the harder problem.

NRx is new prescriptions written in a period. TRx is total prescriptions, new plus refills. NBRx is new-to-brand prescriptions — patients starting the brand who were not previously on it, the cleanest signal of genuine share gain. Closed-loop point-of-care measurement should report all three against a matched control.

It can be, and the mechanism matters more than the assurance. The defensible architecture runs activation on approved business-rule logic against verified provider identity, so the trigger fires on a clinical rule rather than a patient record and no patient-level tracking is required. Ask any vendor whether the integration is direct or resold, and how many parties handle the data.

Omnichannel pharma marketing coordinates messages to healthcare professionals and patients across multiple channels around a single strategy. The practical test is whether the channels are genuinely connected by one signal and one identity, or simply bought separately and arranged in a plan — a sequence versus a set of placements.